SCHEMBL6831346

SCHEMBL6831346

Cc1c(N)nc2cc(N)ccc2c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MDM4 O15151 1/20 0.47
▸ NQO2 P16083 2/20 0.44
▸ LMNA P02545 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ F2 P00734 1/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ MAOA P21397 1/20 0.43
▸ DRD1 P21728 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ OPRM1 P35372 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proflavine SCHEMBL25348298 0.77 LMNA (0.67) MDM4NQO2LMNAMEN1KMT2A
SCHEMBL11703495 0.77 HTR3A (0.52) MDM4NQO2LMNAMEN1KMT2A
SCHEMBL29663215 0.76 DHFR (0.49) MDM4NQO2LMNAMEN1KMT2A
SCHEMBL1118532 0.75 ALDH1A1 (0.53) NQO2LMNAKMT2ACHRM2ADRA2A
SCHEMBL6639402 0.72 POLB (0.61) MDM4NQO2LMNAMEN1KMT2A
SCHEMBL7469561 0.72 ALDH1A1 (0.60) MDM4NQO2LMNAMEN1KMT2A
SCHEMBL8630481 0.72 MDM4 (0.47) MDM4LMNAMEN1KMT2AF2
SCHEMBL17066272 0.72 MDM4 (0.61) MDM4NQO2LMNAMEN1KMT2A
SCHEMBL6094113 0.71 DHFR (0.72) MDM4LMNAMEN1KMT2AF2
SCHEMBL12774935 0.71 ALDH1A1 (0.48) LMNAMEN1KMT2AACHEHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015077550-A1 ARYLQUINOLINE AND ANALOG COMPOUNDS AND USE THEREOF TO TREAT CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2015-05-28 — — WO claimed
WO-2015077550-A1 ARYLQUINOLINE AND ANALOG COMPOUNDS AND USE THEREOF TO TREAT CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2015-05-28 — — WO disclosed
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 — — WO disclosed
Send feedback